Reviews Metozolv ODT


No reviews yet.

Metozolv ODT Drug Description
METOZOLV ODT
(metoclopramide hydrochloride) Orally Disintegrating Tablets

WARNING: TARDIVE DYSKINESIA
Treatment with metoclopramide can cause tardive dyskinesia, a serious movement
disorder that is often irreversible. The risk of developing tardive dyskinesia
increases with duration of treatment and total cumulative dose.
Metoclopramide therapy should be discontinued in patients who develop signs
or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia.
In some patients, symptoms may lessen or resolve after metoclopramide treatment
is stopped.
Treatment with metoclopramide for longer than 12 weeks should be avoided
in all but rare cases where therapeutic benefit is thought to outweigh the
risk of developing tardive dyskinesia. [see WARNINGS AND PRECAUTIONS]

DRUG DESCRIPTION
METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a “5” and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91 mg of metoclopramide hydrochloride ) with gelatin, mannitol, mint flavoring, and Acesulfame K (artificial sweetener). The 10 mg strength is a round white tablet debossed on one side with a “ 10” and plain on the other side; it is comprised of 10 mg metoclopramide (as 11.82 mg of metoclopramide hydrochloride) with gelatin, mannitol, mint flavoring, and Acesulfame K.
The active ingredient, metoclopramide hydrochloride, is a white crystalline,
odorless substance, freely soluble in water. Chemically, it is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy
benzamide monohydrochloride monohydrate. Its molecular formula is C14H22ClN3O2•HCl•H2O.
Its molecular weight is 354.3. The structural formula is shown in Figure 1.
Figure 1








METOZOLV ODT includes the following inactive ingredients: gelatin, mannitol, mint flavoring, Acesulfame Potassium (artificial sweetener), and trace amounts of sodium chloride and sodium hydroxide.
Last reviewed on RxList: 9/30/2009




Metozolv ODT Drug Description
METOZOLV ODT
(metoclopramide hydrochloride) Orally Disintegrating Tablets

WARNING: TARDIVE DYSKINESIA
Treatment with metoclopramide can cause tardive dyskinesia, a serious movement
disorder that is often irreversible. The risk of developing tardive dyskinesia
increases with duration of treatment and total cumulative dose.
Metoclopramide therapy should be discontinued in patients who develop signs
or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia.
In some patients, symptoms may lessen or resolve after metoclopramide treatment
is stopped.
Treatment with metoclopramide for longer than 12 weeks should be avoided
in all but rare cases where therapeutic benefit is thought to outweigh the
risk of developing tardive dyskinesia. [see WARNINGS AND PRECAUTIONS]

DRUG DESCRIPTION
METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a “5” and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91 mg of metoclopramide hydrochloride ) with gelatin, mannitol, mint flavoring, and Acesulfame K (artificial sweetener). The 10 mg strength is a round white tablet debossed on one side with a “ 10” and plain on the other side; it is comprised of 10 mg metoclopramide (as 11.82 mg of metoclopramide hydrochloride) with gelatin, mannitol, mint flavoring, and Acesulfame K.
The active ingredient, metoclopramide hydrochloride, is a white crystalline,
odorless substance, freely soluble in water. Chemically, it is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy
benzamide monohydrochloride monohydrate. Its molecular formula is C14H22ClN3O2•HCl•H2O.
Its molecular weight is 354.3. The structural formula is shown in Figure 1.
Figure 1








METOZOLV ODT includes the following inactive ingredients: gelatin, mannitol, mint flavoring, Acesulfame Potassium (artificial sweetener), and trace amounts of sodium chloride and sodium hydroxide.
Last reviewed on RxList: 9/30/2009




Metozolv ODT Drug Description
METOZOLV ODT
(metoclopramide hydrochloride) Orally Disintegrating Tablets

WARNING: TARDIVE DYSKINESIA
Treatment with metoclopramide can cause tardive dyskinesia, a serious movement
disorder that is often irreversible. The risk of developing tardive dyskinesia
increases with duration of treatment and total cumulative dose.
Metoclopramide therapy should be discontinued in patients who develop signs
or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia.
In some patients, symptoms may lessen or resolve after metoclopramide treatment
is stopped.
Treatment with metoclopramide for longer than 12 weeks should be avoided
in all but rare cases where therapeutic benefit is thought to outweigh the
risk of developing tardive dyskinesia. [see WARNINGS AND PRECAUTIONS]

DRUG DESCRIPTION
METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a “5” and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91 mg of metoclopramide hydrochloride ) with gelatin, mannitol, mint flavoring, and Acesulfame K (artificial sweetener). The 10 mg strength is a round white tablet debossed on one side with a “ 10” and plain on the other side; it is comprised of 10 mg metoclopramide (as 11.82 mg of metoclopramide hydrochloride) with gelatin, mannitol, mint flavoring, and Acesulfame K.
The active ingredient, metoclopramide hydrochloride, is a white crystalline,
odorless substance, freely soluble in water. Chemically, it is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy
benzamide monohydrochloride monohydrate. Its molecular formula is C14H22ClN3O2•HCl•H2O.
Its molecular weight is 354.3. The structural formula is shown in Figure 1.
Figure 1








METOZOLV ODT includes the following inactive ingredients: gelatin, mannitol, mint flavoring, Acesulfame Potassium (artificial sweetener), and trace amounts of sodium chloride and sodium hydroxide.
Last reviewed on RxList: 9/30/2009




Metozolv ODT Drug Description
METOZOLV ODT
(metoclopramide hydrochloride) Orally Disintegrating Tablets

WARNING: TARDIVE DYSKINESIA
Treatment with metoclopramide can cause tardive dyskinesia, a serious movement
disorder that is often irreversible. The risk of developing tardive dyskinesia
increases with duration of treatment and total cumulative dose.
Metoclopramide therapy should be discontinued in patients who develop signs
or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia.
In some patients, symptoms may lessen or resolve after metoclopramide treatment
is stopped.
Treatment with metoclopramide for longer than 12 weeks should be avoided
in all but rare cases where therapeutic benefit is thought to outweigh the
risk of developing tardive dyskinesia. [see WARNINGS AND PRECAUTIONS]

DRUG DESCRIPTION
METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a “5” and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91 mg of metoclopramide hydrochloride ) with gelatin, mannitol, mint flavoring, and Acesulfame K (artificial sweetener). The 10 mg strength is a round white tablet debossed on one side with a “ 10” and plain on the other side; it is comprised of 10 mg metoclopramide (as 11.82 mg of metoclopramide hydrochloride) with gelatin, mannitol, mint flavoring, and Acesulfame K.
The active ingredient, metoclopramide hydrochloride, is a white crystalline,
odorless substance, freely soluble in water. Chemically, it is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy
benzamide monohydrochloride monohydrate. Its molecular formula is C14H22ClN3O2•HCl•H2O.
Its molecular weight is 354.3. The structural formula is shown in Figure 1.
Figure 1








METOZOLV ODT includes the following inactive ingredients: gelatin, mannitol, mint flavoring, Acesulfame Potassium (artificial sweetener), and trace amounts of sodium chloride and sodium hydroxide.
Last reviewed on RxList: 9/30/2009




Metozolv ODT Drug Description
METOZOLV ODT
(metoclopramide hydrochloride) Orally Disintegrating Tablets

WARNING: TARDIVE DYSKINESIA
Treatment with metoclopramide can cause tardive dyskinesia, a serious movement
disorder that is often irreversible. The risk of developing tardive dyskinesia
increases with duration of treatment and total cumulative dose.
Metoclopramide therapy should be discontinued in patients who develop signs
or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia.
In some patients, symptoms may lessen or resolve after metoclopramide treatment
is stopped.
Treatment with metoclopramide for longer than 12 weeks should be avoided
in all but rare cases where therapeutic benefit is thought to outweigh the
risk of developing tardive dyskinesia. [see WARNINGS AND PRECAUTIONS]

DRUG DESCRIPTION
METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a “5” and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91 mg of metoclopramide hydrochloride ) with gelatin, mannitol, mint flavoring, and Acesulfame K (artificial sweetener). The 10 mg strength is a round white tablet debossed on one side with a “ 10” and plain on the other side; it is comprised of 10 mg metoclopramide (as 11.82 mg of metoclopramide hydrochloride) with gelatin, mannitol, mint flavoring, and Acesulfame K.
The active ingredient, metoclopramide hydrochloride, is a white crystalline,
odorless substance, freely soluble in water. Chemically, it is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy
benzamide monohydrochloride monohydrate. Its molecular formula is C14H22ClN3O2•HCl•H2O.
Its molecular weight is 354.3. The structural formula is shown in Figure 1.
Figure 1








METOZOLV ODT includes the following inactive ingredients: gelatin, mannitol, mint flavoring, Acesulfame Potassium (artificial sweetener), and trace amounts of sodium chloride and sodium hydroxide.
Last reviewed on RxList: 9/30/2009





Other reviews about Metozolv ODT on web:

Metozolv ODT is an orally disintegrating metoclopramide tablet for acute and recurrent diabetic gastroparesis and short-term treatment for refractory GERD. Metoclopramide HCl Orally Disintegrating Tablets | Metozolv ODT


Metozolv ODT (metoclopramide) is a new drug formulation in development for the treatment of GERD and gastroparesis. Metozolv ODT information includes news, clinical trial results ... Salix Announces FDA Complete Response Letter for Metozolv ODT


Metozolv ODT (metoclopramide ) is used to treat diabetic gastroparesis and gastroesophageal reflux disease. Includes Metozolv ODT side effects, interactions and indications. Metozolv ODT Information from Drugs.com


Learn about the prescription medication Metozolv ODT (Metoclopramide Hydrochloride Orally Disintegrating Tablets), drug uses, dosage, side effects, drug interactions, warnings ... Metozolv ODT (Metoclopramide Hydrochloride Orally Disintegrating ...


METOZOLV ODT is the first available orally disintegrating tablet for relief of diabetic gastroparesis and refractory GERD. Metozolv ODT (metoclopramide HCl) | Refractory GERD & Diabetic ...


Organized by therapeutic area, this comprehensive listing of FDA-Approved Drugs by the Food and Drug Administration features facts on clinical trial results, side effects and ... Newly Approved Drug Therapies (1054) Metozolv ODT (metoclopramide ...


Metozolv ODT is an orally disintegrating metoclopramide tablet indicated for acute and recurrent diabetic gastroparesis and short-term treatment (4-12 weeks) for refractory GERD. For Healthcare Professionals | Metozolv ODT (metoclopramide ...


FULL PRESCRIBING INFORMATION WARNING: TARDIVE DYSKINESIA Treatment with metoclopramide can cause tardive dyskinesia, a serious movement disorder that is often irreversible. Metozolv ODT (metoclopramide HCl) Prescribing Information


NDA 22-246 METOZOLV™ ODT (metoclopramide hydrochloride) Orally Disintegratin g Tablets 5 mg & 10 mg METOZOLV ODT (metoclopramide hydrochloride) Orally Disintegrating Tablets ... METOZOLV ODT (metoclopramide hydrochloride) Orally Disintegrating ...


Drug information and side-effects for Metozolv ODT (metoclopramide hydrochloride) Metozolv ODT (metoclopramide hydrochloride) - Drug information ...





Featured Reviews

Reviews Limbrel

Limbrel Drug Description LIMBREL™ (flavocoxid™) Capsules by Oral Administration. Dispensed by prescription. (U.S. patents 7,108,868 and 7,192,611; other patents pending.) A specially formulated medical food product, consisting...
Read More  |  Review This
Reviews Penicillamine

Cuprimine Drug Description CUPRIMINE® (penicillamine) Capsules Physicians planning to use penicillamine should thoroughly familiarize themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine...
Read More  |  Review This
Reviews Oleptro

Oleptro Drug Description OLEPTRO (trazodone hydrochloride) Extended-Release Tablets WARNING SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality)...
Read More  |  Review This
Reviews Nafarelin Acetate Nasal Solution for Endometriosis

Synarel Nasal Solution Drug Description Synarel® (nafarelin acetate) Nasal Solution ENDOMETRIOSIS DRUG DESCRIPTION What are the possible side effects of nafarelin nasal (Synarel)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Alprostadil Sterile Powder for Injection

Caverject Powder Drug Description Caverject® (alprostadil) Sterile Powder For Intracavernosal Use DRUG DESCRIPTION What are the possible side effects of alprostadil (Caverject, Caverject Impulse, Edex, Muse, Prostin VR Pediatric)? Get...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....